Recent Updates
Recently added Catalysts
ACH Neutral Sentiment Score: 55/100

Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition OMI Remains Committed to Continued Growth in the Strong Home-based Care Market Will Focus on Deleveraging & Driving Profita

Key Takeaway: Owens & Minor has mutually agreed with Rotech Healthcare to terminate their acquisition, which involved a payment of $80 million. The company faced challenges in obtaining regulatory clearance, making the merger unfeasible in terms of time and costs. Despite this setback, Owens & Minor is committed to growing its Patient Direct business and improving its financial health through deleveraging. The home-based care market remains a focal point for the company as they continue to explore opportunities for strengthening their business.

Market Sentiment Analysis

POSITIVE FACTORS

  • Owens & Minor remains committed to growth in the home-based care market.
  • The company is focused on deleveraging and driving profitable growth.
  • Efforts to strengthen business and explore potential sales are ongoing.

CONCERNS & RISKS

  • The acquisition termination involved an $80 million payment to Rotech Healthcare.
  • Regulatory clearance for the merger was deemed unviable due to time and expense.
  • The inability to complete the acquisition may lead to missed opportunities.

Full Press Release Details

Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition
OMI Remains Committed to Continued Growth in the Strong Home-based Care Market
Will Focus on Deleveraging & Driving Profitable Growth
RICHMOND, VA June 5, 2025 Owens & Minor, Inc. (NYSE: OMI) today announced it has mutually agreed with Rotech Healthcare
Holdings Inc. to terminate the previously announced acquisition. Under the terms of the merger agreement, Owens & Minor has paid $80 million to Rotech Healthcare. Owens & Minor will also redeem the $1 billion of notes
issued in April 2025, that include a special mandatory redemption provision in accordance with their terms, and terminate the incremental term loan commitments and senior unsecured bridge loan commitments provided by our lenders that would have been
utilized to consummate the acquisition.
For many months, our teammates along with the Rotech team have worked tirelessly in cooperation with the
Federal Trade Commission to close this transaction, and while we believe there would have been an ample benefits to patients, payors and providers by adding Rotech to our Patient Direct business, however, the path to obtain regulatory clearance for
this merger proved unviable in terms of time, expense, and opportunity, said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.
We are confident in our strategy and will continue to focus our efforts on growing our Patient Direct business while remaining committed to
strengthening our balance sheet through the use of improved cash flow generation for deleveraging. The home-based care market is a dynamic, growing market and we are extremely well positioned to help those with chronic conditions get the care and
service they need and deserve. Also, we continue to work with a number of interested parties around the potential sale of our Products and Healthcare Services business and in the meantime, we will continue to actively work to strengthen that
business and tap into its significant upside .
I want to thank our teammates, partners and everyone at Rotech for their effort and cooperation
over the last several months and we look forward to a bright future with many years profitable growth, Pesicka concluded.
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products
and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria ,
Byram and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers
comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care . For more information about
This press release shall not constitute an offer to buy the notes issued in April 2025, which will be conducted pursuant to a special mandatory redemption in
accordance with the terms of the notes.
Jackie Marcus or Nick Teves

Frequently Asked Questions

Why did Owens & Minor terminate the Rotech acquisition?

Owens & Minor and Rotech mutually agreed to terminate the acquisition due to challenges in obtaining regulatory clearance.

What payment did Owens & Minor make to Rotech?

Owens & Minor paid $80 million to Rotech Healthcare in connection with the terminated acquisition.

What is Owens & Minor's future focus?

Owens & Minor will concentrate on deleveraging and driving profitable growth in the home-based care market.

How long has Owens & Minor been in the healthcare business?

Owens & Minor has been providing healthcare solutions for over 100 years.

What is the status of Owens & Minor's Products and Healthcare Services business?

Owens & Minor is exploring a potential sale of its Products and Healthcare Services business while enhancing its growth.

Last updated: Jun 5, 2025